IB Lab GECKO

Support for Vertebral Fracture Assessment (VFA)

Get Demo

The Challenge

How to accurately detect, quantify and predict osteoporotic fractures in elderly patients?

Osteoporosis is a disease characterized by the loss of mass and degradation of the internal structures of the bone. The difficulty of detection of osteoporosis-related fractures is leading to a lack of diagnosis and timely provided treatment.

The main challenges in diagnostics of osteoporosis provide an optimal use case to use AI-supported software: 

  • Low detection: it is estimated that in 80% of the high-risk patients, the disease is not identified nor treated adequately 
  • High discrepancy - 62.5% discrepancy between specialists and assistant physicians 
  • High error rate - 69% of the fractures were not immediately detected (an increase of 14% high workloads)

All this results in problems with case prioritization and patient outcomes.

The Solution

An example of applying AI-supported software to improve the detection of osteoporotic fractures using established and novel imaging biomarkers 

IB Lab GECKO is a fully automated software application intended to assist physicians in the measurement of vertebral heights; and an assessment of the presence or absence of vertebral fractures based on the Genant Grade criteria. Moreover, GECKO deploys proprietary bone microarchitecture algorithms which provide valuable insights into the strength and quality of the bone. Such insights can be instrumental in predicting a fracture, giving the physician time to apply the bone-strengthening treatment. 

IB Labs GECKO is unique in its way of achieving a zero-click, seamless integration into existing reporting workflows. Industry-standard output formats enable customizable report generation.  Results are calculated within seconds, stored in PACS, and are available in the DICOM viewer as printable PDF reports for the referring physicians.

Opportunities for physicians and patients

Novel imaging biomarkers will enable a change of management by applying medication even before a fracture has occurred 

  • Pre-screening of studies reduces the chances of missing a fracture and prioritize patients who need to be sent to a Fracture Liaison Service
  • Automated time series analysis of fracture progression can be linked to treatment impact and progression
  • Novel imaging biomarkers complement existing diagnostic standards, strengthening the detection and prediction of incident osteoporotic fractures. Targeted treatment has the potential to reduce suffering and improve the quality of life of patients affected by Osteoporosis

What our customers say:

Jack Farr - Orthopedist

ImageBiopsy AI software is highly accurate and efficient within our PACS system, which provides valuable information on the status of the knee along the continuum of chondrosis to arthrosis.

Jack Farr, MD
Orthopedist

The integration of the AI ​​solutions by ImageBiopsy Lab into our RIS and PACS is easy and well done. It is fun to work with and the clarity of the visualized report is an ideal support for our patient consultation.

Jochen Mueller-Stromberg, MD
Orthopedist

AI-based solutions reduce the amount of work and the findings become more accurate. An objective value is given which can be used both for monitoring and forecasting the progress. We offer something that others don’t have.

Michael Gruber, MD
Radiologist

Exact diagnosis and reproducible follow-up exams are indispensable for a successful osteoarthritis therapy. Software-based methods can assist the physician in the therapy management and adjustment process.

Prof. Jochen Hofstätter, MD
Orthopedist